1 |
Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Dcbatin, K. M. and Krammer, P. H. : Science 245, 301 (1989)
|
2 |
Suda, T., Takahashi, T., Golstem, P. and Nagata, S. : Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169 (1993)
DOI
ScienceOn
|
3 |
Cho, Y. B., Kim K. H. and Kim D. K. : Pharmacokinetucs, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) in dogs. Drug Metab. Dispos. 23, 1280 (1995).
|
4 |
Owen-Schanb, L. B., Yonehara, S., Crump, W. D. and Grimm, E. A. : J. Cell Immunol. 140, 197 (1992)
DOI
ScienceOn
|
5 |
McGahon, A. J., Nishioka, W. K., Martin, S. J., Mahboubi, A., Cotter, T.G. and Green, D. R. : Regulation of the Fas Apoptotic cell Death Pathway by Abl. J. Biol. Chem. 270, 22625 (1995)
DOI
ScienceOn
|
6 |
Korsmeyer S. J. : BcI-2 initiate a new category of oncogenes; regulators of cell death. Bolld 80, 879 (1992)
|
7 |
Kerr, J. F. R., Wyllie, A. H. and Currie, A. R. : Apoptosis : a basic biological phenomenon with wide-ranging implications in tissue Kinetics. Br. J. Cancer 26, 239 (1972)
DOI
ScienceOn
|
8 |
서정선 : 20세기말의 의.생물학의 새로운 비전, 아포프토시스 (Apoptosis). Korean Society of Medical Biochemistry and Molecular, Biology News. 30
|
9 |
Oehm, A., Behrmann, I., Falk, W.,Pawlita, M., Maier, G., KIas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B. C., Ponstingl, H. and Krammer, P. H.: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily, sequence identity with the Fasantigen. J. Biol. Chem. 267, 10709 (1992)
|
10 |
Choi, S. L. and Myung, P. K. : Cell viability and flow cytometry analysis of a novel antitumor agent, Heptaplatin in human melanoma cell line, SK-MEL-28. Yakhak Hoejl 47(6), 345 (2003)
|
11 |
McGahon, A. J., Martin, S. J., Bissonnette, R., Mahboubi, A., Shi, Y., Mogil, R., Nishioka, N. and Green, D. R. : The end of the cell line : methods for the study of apoptosis in vitro. Method Cell Biol. 46, 153 (1995)
|
12 |
Nagata, S. and Golstin, P. : Science 267, 1449 (1995)
|
13 |
Orlinick, J. R., Vaishnaw, A., Elkon, K. B. and Chac, M. V. : Requirement of cystein-rich receptors of the Fas Receptors for Binding by the Fas Ligand. J. Biol. Chem. 272, 288W (1997)
|
14 |
Yin, X. M., Oltvai, Z. N. and Korsmeyer, S. J. : BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 369, 321 (1994)
DOI
ScienceOn
|
15 |
Itoh, N., Yonehara, S., Ishil, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Negata, S. : The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233 (1991)
DOI
ScienceOn
|
16 |
Hockenbery, D. M. : BcI-2, a novel regulator of cell death. BioEssays 17, 631 (1995)
DOI
PUBMED
ScienceOn
|
17 |
Yonehara, S., Ishii, A. and Yonehara, M. : A cell-killing monoclonal antibidy (anti-Fas) to a cell surface antigene codown regulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747 (1989)
DOI
ScienceOn
|
18 |
Boise, L. H., Gottschalk, A. R., Quintans, J. and Thombson, C. B. : Curr. Topics Microbiol. Immunol. 200, 107 (1995).
|
19 |
Oltvai, Z. N., Milliman, C. L. and Korsmeyer, S. J. : Bcl-2 heterodimerizes in vivo with a conserved homolog box, that accelerates programmed cell death. Cell 369, 609 (1991)
|
20 |
Trauth, B. C., KIas, C., Peters, A. M. J., Matzku, S., Moller, P., Falk, W., Debatin, K. M. and Krammer, P. H. : Science 245, 301 (1989)
|